|
Guest
|
Most recent articles on bladder cancer:
Does the Presence of Jaundice and/or a Lump in a Patient with Gall
Bladder Cancer Mean that the Lesion Is Not Resectable?
Varma V, Gupta S, Soin AS, Nundy S.
Dig Surg. 2009 Aug 5;26(4):306-311.
Bladder cancer: work in progress.
Stenzl A.
Curr Opin Urol. 2009 Sep;19(5):486-7.
Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518
polymorphism in Mexican patients with transitional cell carcinoma of
the bladder.
Vázquez-Lavista LG, Lima G, Gabilondo F, Llorente L.
Urology. 2009 Aug;74(2):414-8.
Effect of vascular endothelial growth factor and its receptor
inhibitor on proliferation and invasion in bladder cancer.
Nakanishi R, Oka N, Nakatsuji H, Koizumi T, Sakaki M, Takahashi M,
Fukumori T, Kanayama HO.
Urol Int. 2009;83(1):98-106.
ryo_yah3 at (no spam) yahoo.co.jp
Intravesical immunotherapy of superficial bladder cancer with chitosan/
interleukin-12.
Zaharoff DA, Hoffman BS, Hooper HB, Benjamin CJ Jr, Khurana KK, Hance
KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW.
Cancer Res. 2009 Aug 1;69(15):6192-9.
InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb at (no spam) mail.com) |
|
|
